Veru, Inc. (VERU)
2.30
-0.14
(-5.74%)
USD |
NASDAQ |
Oct 16, 16:00
2.29
-0.01
(-0.43%)
After-Hours: 20:00
Veru Free Cash Flow (Quarterly) : -5.467M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.467M |
| March 31, 2026 | -8.915M |
| December 31, 2025 | -6.170M |
| September 30, 2025 | -5.491M |
| June 30, 2025 | -5.482M |
| March 31, 2025 | -7.736M |
| December 31, 2024 | -11.33M |
| September 30, 2024 | -4.429M |
| June 30, 2024 | -5.700M |
| March 31, 2024 | -5.691M |
| December 31, 2023 | -6.020M |
| September 30, 2023 | -9.705M |
| June 30, 2023 | -18.46M |
| March 31, 2023 | -25.70M |
| December 31, 2022 | -34.82M |
| September 30, 2022 | -21.03M |
| June 30, 2022 | -14.12M |
| March 31, 2022 | -4.132M |
| December 31, 2021 | -8.96M |
| September 30, 2021 | -1.029M |
| June 30, 2021 | -12.98M |
| March 31, 2021 | -2.594M |
| December 31, 2020 | 0.652M |
| September 30, 2020 | -0.3734M |
| June 30, 2020 | 3.320M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.450M |
| December 31, 2019 | -2.532M |
| September 30, 2019 | -0.9886M |
| June 30, 2019 | -0.6019M |
| March 31, 2019 | -2.497M |
| December 31, 2018 | -1.506M |
| September 30, 2018 | -2.818M |
| June 30, 2018 | -4.474M |
| March 31, 2018 | -4.600M |
| December 31, 2017 | 0.2948M |
| September 30, 2017 | 0.5633M |
| June 30, 2017 | 1.430M |
| March 31, 2017 | -2.244M |
| December 31, 2016 | 1.100M |
| September 30, 2016 | -0.8256M |
| June 30, 2016 | 0.4193M |
| March 31, 2016 | -0.8802M |
| December 31, 2015 | -0.4341M |
| September 30, 2015 | 1.481M |
| June 30, 2015 | -0.3089M |
| March 31, 2015 | -1.634M |
| December 31, 2014 | -1.222M |
| September 30, 2014 | 2.174M |
| June 30, 2014 | 0.3123M |
| March 31, 2014 | -0.0179M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 53.62M |
| Corcept Therapeutics, Inc. | 31.02M |
| Johnson & Johnson | 7.295B |
| Eli Lilly & Co. | 4.475B |
| Lexicon Pharmaceuticals, Inc. | -9.192M |